Gevo (GEVO) Lowered to Hold at Zacks Investment Research

Gevo (NASDAQ:GEVO) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research report issued to clients and investors on Tuesday.

According to Zacks, “Gevo, Inc. is a renewable chemicals and advanced biofuels company engaged in the development of biobased alternatives to petroleum-based products using a combination of synthetic biology and chemistry. The Company is focused on the commercialization of isobutanol, a naturally occurring four carbon alcohol with broad applications in large chemicals and fuels markets. Isobutanol can be used as a solvent and a gasoline blendstock and can be further processed into jet fuel and feedstocks for the production of synthetic rubber, plastics and polyesters. Markets served by the Company include solvents and coatings, materials, plastics and fibers, biojet blendstock, gasoline blendstock and other hydrocarbon fuels. “

Other equities research analysts also recently issued research reports about the company. HC Wainwright downgraded Gevo from a “buy” rating to a “neutral” rating and set a $12.00 price target for the company. in a report on Tuesday. ValuEngine downgraded Gevo from a “sell” rating to a “strong sell” rating in a report on Monday, October 2nd.

Shares of Gevo (NASDAQ:GEVO) remained flat at $$0.61 during midday trading on Tuesday. The stock had a trading volume of 1,189,800 shares, compared to its average volume of 762,017. The company has a debt-to-equity ratio of 0.21, a current ratio of 1.54 and a quick ratio of 1.23. The firm has a market cap of $13.30, a price-to-earnings ratio of -0.35 and a beta of 3.09. Gevo has a twelve month low of $0.53 and a twelve month high of $4.98.

Gevo (NASDAQ:GEVO) last issued its quarterly earnings results on Monday, November 6th. The energy company reported ($0.36) earnings per share for the quarter, topping the consensus estimate of ($0.41) by $0.05. The business had revenue of $7.70 million during the quarter, compared to the consensus estimate of $5.49 million. Gevo had a negative return on equity of 40.58% and a negative net margin of 84.42%. equities analysts anticipate that Gevo will post -1.69 earnings per share for the current fiscal year.

Several large investors have recently made changes to their positions in the company. Virtu KCG Holdings LLC raised its stake in shares of Gevo by 557.6% in the second quarter. Virtu KCG Holdings LLC now owns 182,390 shares of the energy company’s stock worth $126,000 after purchasing an additional 154,654 shares during the last quarter. Vanguard Group Inc. raised its stake in shares of Gevo by 22.4% in the second quarter. Vanguard Group Inc. now owns 486,959 shares of the energy company’s stock worth $336,000 after purchasing an additional 89,020 shares during the last quarter. Sabby Management LLC purchased a new position in shares of Gevo in the first quarter worth about $1,274,000. KBC Group NV raised its stake in shares of Gevo by 40.8% in the third quarter. KBC Group NV now owns 240,843 shares of the energy company’s stock worth $116,000 after purchasing an additional 69,743 shares during the last quarter. Finally, State Treasurer State of Michigan raised its stake in shares of Gevo by 8.9% in the second quarter. State Treasurer State of Michigan now owns 836,448 shares of the energy company’s stock worth $494,000 after purchasing an additional 68,301 shares during the last quarter. Hedge funds and other institutional investors own 7.07% of the company’s stock.

COPYRIGHT VIOLATION WARNING: “Gevo (GEVO) Lowered to Hold at Zacks Investment Research” was originally posted by American Banking News and is the property of of American Banking News. If you are viewing this report on another domain, it was stolen and republished in violation of US & international copyright and trademark laws. The correct version of this report can be accessed at https://www.americanbankingnews.com/2018/01/09/gevo-gevo-lowered-to-hold-at-zacks-investment-research.html.

Gevo Company Profile

Gevo, Inc (Gevo) is a renewable chemicals and next generation biofuels company. The Company has developed a technology that uses a combination of synthetic biology, metabolic engineering, chemistry and chemical engineering to focus primarily on the production of isobutanol, as well as related products from renewable feedstock.

Get a free copy of the Zacks research report on Gevo (GEVO)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Gevo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gevo and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply